CD274 and neoplasm: In particular, in the setting of anti-PD1/PDL1 therapy, where a possible mechanism of action is the revitalization of pre-existing T cell-mediated responses [88], the phenotype of tumor-infiltrating lymphocytes (TILs) could play a central role in predicting patients’ clinical outcome.